Bank of America
ADMA icon

Bank of America’s ADMA Biologics ADMA Stock Holding History

Bank of America’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-22,700
Closed -$333K – 7297
2025
Q3 		$333K Hold
22,700
– – ﹤0.01% 6024
2025
Q2 		$413K Buy
+22,700
New +$463K ﹤0.01% 5819

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Bank of America's ADMA Position: Q1 2026 in Review

Bank of America increased its ADMA Biologics (ADMA) stake by 108% in Q1 2026, buying an estimated $32.7M and bringing the position to 3,997,675 shares worth $36M. The position accounts for ﹤0.01% of the portfolio, ranked #1875.

Bank of America first reported a position in ADMA in Q4 2015 and has held it in 40 quarters since. 356 funds tracked by Wall St. Rank hold ADMA as of Q1 2026.

  • Bank of America held 3,997,675 shares of ADMA Biologics worth $36M as of Q1 2026.
  • Bank of America bought 2,071,338 ADMA Biologics shares in Q1 2026, an estimated $32.7M.
  • ADMA Biologics made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #1875 holding.
  • Bank of America first reported a position in ADMA Biologics in Q4 2015 and has held it in 40 quarters since.
  • 356 funds tracked by Wall St. Rank held ADMA Biologics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.